SCHEMBL17896054

SCHEMBL17896054

COCCCn1ncc2c1CC[C@H](C)c1c-2[nH]c(=O)c(C(=O)O)c1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17896055 0.86 HSD11B1 (0.32) —
SCHEMBL17895983 0.83 PLK1 (0.36) —
SCHEMBL17895994 0.83 PLK1 (0.36) —
SCHEMBL17895885 0.83 PLK1 (0.36) —
SCHEMBL17896048 0.83 USP2 (0.33) —
SCHEMBL17896046 0.79 KDM4E (0.32) —
SCHEMBL17896107 0.77 USP2 (0.34) —
SCHEMBL17895841 0.72 ELANE (0.32) —
SCHEMBL17901949 0.71 — —
SCHEMBL17895749 0.70 CCNA2 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016109706-A1 FUSED POLYCYCLIC 2-PYRIDINONE ANTIBACTERIAL COMPOUNDS PTC THERAPEUTICS, INC. (US) 2016-07-07 — — WO claimed
WO-2016109706-A1 FUSED POLYCYCLIC 2-PYRIDINONE ANTIBACTERIAL COMPOUNDS PTC THERAPEUTICS, INC. (US) 2016-07-07 — — WO disclosed
Send feedback